Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.73 | N/A |
| PEG Ratio (TTM) | -6.40 | N/A |
| P/S Ratio (TTM) | 1.68 | N/A |
| P/B Ratio (TTM) | 0.65 | N/A |
| P/FCF Ratio (TTM) | -9.51 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.56 | N/A |
| Price to 5YR AVG FCF Ratio | -14.70 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.31% | N/A |
| ROE (TTM) | 3.67% | N/A |
| Net Profit Margin (TTM) | 9.52% | N/A |
| ROIC 5YR AVG | 7.46% | N/A |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.80% | 28.45% | 2.55% |
| Revenue | -0.10% | -0.39% | 1.56% |
| Net Income | 21.40% | 21.06% | -1.41% |
| Cash Flow | -162.92% | 67.22% | -50.06% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.49 | N/A |
| Quick Ratio (TTM) | 3.49 | N/A |
| D/E Ratio (TTM) | 1.43 | N/A |
| Interest Coverage (TTM) | 0.12 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.43 | N/A |
| LTL to 5YR AVG FCF | -30.19 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.94% | N/A |